1. Abubaker, Y., Perez, R., Pike, M., Zalupski, M., & Fuloria J. (2005). A Phase I trial of DAVANAT®, a galactose pronged polymannose co-administered with 5-fluorouracil, in patients with refractory solid tumors. In Meeting: Gastrointestinal cancers symposium session type and session title: Cancers of the colon and rectum—General poster session Abstract No. 270.
2. Colonic transit of different sized tablets in healthy subjects;Adkin;Journal of Controlled Release,1993
3. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms, Ht;Alderman;International Journal of Pharmaceutical Technology & Product Manufacture,1984
4. Targeted therapies in the treatment of colorectal cancers;Alekshun;Cancer Control,2005
5. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery;Ali Asgar;Drug Delivery,2009